Rating: Buy
Bristol-Myers Squibb Financial Health
Profitability:2.67/10
❌ Bristol-Myers Squibb has worst Profitability than 77.78% of the companies on the Drug Manufacturers industry
Net Margin: -1.61%
❌ Bristol-Myers Squibb has worst Net Margin than 66.67% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): -0.33%
❌ Bristol-Myers Squibb has worst ROE (Return on Equity) than 66.67% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): -0.13%
❌ Bristol-Myers Squibb has worst ROA (Return on Assets) than 66.67% of the companies on the Drug Manufacturers industry
Operating Efficiency:9.49/10
✅ Bristol-Myers Squibb has better Operating Efficiency than 66.67% of the companies on the Drug Manufacturers industry
Operating Margin: 49.13%
✅ Bristol-Myers Squibb has better Operating Margin than 66.67% of the companies on the Drug Manufacturers industry
Liquidity:5.94/10
✅ Bristol-Myers Squibb has better Liquidity than 83.33% of the companies on the Drug Manufacturers industry
Quick Ratio: 1.36
✅ Bristol-Myers Squibb has better Quick Ratio than 83.33% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.54
❌ Bristol-Myers Squibb has worst Operating Cash Flow Ratio than 66.67% of the companies on the Drug Manufacturers industry
Solvency:4.53/10
❌ Bristol-Myers Squibb has worst Solvency than 66.67% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 0.95
❌ Bristol-Myers Squibb has worst Debt to Equity Ratio than 50% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.54
❌ Bristol-Myers Squibb has worst Interest Coverage Ratio than 66.67% of the companies on the Drug Manufacturers industry